Medincell Depreciation & Amortization Growth & History (MEDCL)
Medincell's depreciation and amortization was €1.8M for fiscal 2026.
View full Medincell company overviewMedincell annual depreciation and amortization history
2021
2022
2023
2024
2025
2026
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | €1.8M | −€166,000 | −8.34% |
| 2025 | 2025-03-31 | €2.0M | €271,000 | +15.76% |
| 2024 | 2024-03-31 | €1.7M | €54,000 | +3.24% |
| 2023 | 2023-03-31 | €1.7M | €149,000 | +9.83% |
| 2022 | 2022-03-31 | €1.5M | €177,000 | +13.22% |
| 2021 | 2021-03-31 | €1.3M | — | — |
Medincell depreciation and amortization trends
Over the last five fiscal years, Medincell's depreciation and amortization increased from €1.3M to €1.8M, a change of €485,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medincell source filings ↗